Author:
Fasseeh Ahmad Nader,Elezbawy Baher,Gamal Mary,Seyam Ahmed,Abourawash Asmaa,George Mohsen,Anwar Mohamed,Amin Magdy,Khalifa Ahmed Yehia,Elshalakani Amr,Hatem Ashraf,Abdelhamid Sohir,Elsamouly Hossam,Fasseeh Nader,Adel Randa,Dawood Hatem,Abaza Sherif,Kaló Zoltán
Abstract
BackgroundThe Egyptian healthcare system is currently in the early phase of health technology assessment (HTA) implementation. The aim of this study is to propose an implementation roadmap based on the national healthcare system status.MethodsA survey was conducted among Egyptian healthcare sector decision-makers to assess the current and future (preferred) HTA implementation status in Egypt based on a widely used international scorecard methodology. Subsequently, interviews were conducted with experts representing middle- and top-tier management in the Egyptian healthcare system to interpret the survey results and recommend specific actions.ResultsExperts recommended more capacity-building programs for HTA and health economics. Additionally, they proposed establishing HTA units in separate healthcare authorities and merging them into a single central HTA unit in the long term. Regarding the scope of implementation, experts recommended commencing with the assessment of innovative pharmaceuticals, and thereafter, expanding the scope to cover all health technologies in the long term. Additionally, they recommended using innovative tools such as “multi-criteria decision analysis (MCDA)” for tendering, and “managed entry agreements” for reimbursement decisions. Local burden of diseases and costing studies were also recommended to facilitate the implementation of HTA.ConclusionExperts agreed that several actions are required for successful HTA implementation in Egypt, including coordination between HTA bodies, application of an explicit MCDA framework, and strengthening of local evidence generation. To implement these actions, investment in technical capacity-building is indispensable. Most experts favored using multiple and soft cost-effectiveness thresholds. Efforts should be made to publish HTA submission guidelines and timelines of the processes.
Funder
Janssen Pharmaceuticals
Takeda Pharmaceutical Company
Subject
Public Health, Environmental and Occupational Health
Reference31 articles.
1. Egypt GDP per capita.2020
2. Egypt Population 2020.2020
3. Egypt: Health systems strengthening towards universal health coverage - Regional Office for the Eastern Mediterranean.2014
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献